L. Jarolím

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

Michal Podrazil, Rudolf Horváth, Étienne Becht et al. · Oncotarget · 2015 · 136 citations · Full text

Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors

Arnulf Stenzl, L. Jarolím, P. Coloby et al. · Cancer · 2001 · 133 citations · Full text

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

Marek Babjuk, M. Koštířová, Katalin Mudra et al. · European Urology · 2002 · 64 citations

Urology, Transitional Cell Carcinoma, Genitourinary Cancer +7

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

Jitka Fučíková, Michal Podrazil, L. Jarolím et al. · Cancer Immunology Immunotherapy · 2017 · 45 citations · Full text

Urology, Cancer Immunosurveillance, Salvage Radiotherapy +9

Surgical conversion of genitalia in transsexual patients

L. Jarolím · British Journal of Urology · 2000 · 43 citations